Literature DB >> 24913270

The common marmoset as a model for the study of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

J A Kramer1, J Grindley2, A M Crowell3, L Makaron1, R Kohli4, M Kirby4, K G Mansfield5, L M Wachtman6.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome. The more clinically concerning form of the disease, nonalcoholic steatohepatitis (NASH), is characterized by steatosis, lobular inflammation, and ballooning degeneration. Here we describe a naturally occurring syndrome in the common marmoset that recapitulates the pathologic findings associated with NAFLD/NASH in humans. Hepatomegaly determined to result from NAFLD was observed in 33 of 183 marmosets. A comprehensive histopathologic assessment performed in 31 marmosets demonstrated that NAFLD was characterized by variably sized, Oil Red O staining cytoplasmic vacuoles and observed primarily in animals with evidence of obesity and insulin resistance. A subset of marmosets (16 of 31) also demonstrated evidence of NASH characterized by multifocal inflammation combined with ballooning hepatocellular degeneration. Marmosets with NASH demonstrated an increase in immunostaining with an antibody targeted against the human leukocyte antigens (HLA)-DP, HLA-DQ, and HLA-DR compared with marmosets without NASH (38.89 cells/10× field vs 12.05 cells/10× field, P = .05). In addition, marmosets with NASH demonstrated increased Ki-67 immunopositive cellular proliferation compared with those without (5.95 cells/10× field vs 1.53 cells/10× field, P = .0002). Finally, animals with NASH demonstrated significantly increased mean circulating serum iron levels (160.47 μg/dl, P = .008) and an increase in numbers of Prussian blue-positive Kupffer cells (9.28 cells/40× field, P = .005) relative to marmosets without NASH (97.75 μg/dl and 1.87 cells/40×, respectively). This study further characterizes the histopathology of NAFLD/NASH and suggests that the marmoset may be a valuable animal model with which to investigate the host and environmental factors contributing to the progression of NAFLD/ NASH.
© The Author(s) 2014.

Entities:  

Keywords:  Callithrix jacchus; hemosiderosis; hepatic siderosis; marmoset; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis

Mesh:

Year:  2014        PMID: 24913270     DOI: 10.1177/0300985814537839

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  9 in total

Review 1.  Use and Importance of Nonhuman Primates in Metabolic Disease Research: Current State of the Field.

Authors:  Peter J Havel; Paul Kievit; Anthony G Comuzzie; Andrew A Bremer
Journal:  ILAR J       Date:  2017-12-01

Review 2.  The common marmoset monkey: avenues for exploring the prenatal, placental, and postnatal mechanisms in developmental programming of pediatric obesity.

Authors:  Laren Riesche; Suzette D Tardif; Corinna N Ross; Victoria A deMartelly; Toni Ziegler; Julienne N Rutherford
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-02-07       Impact factor: 3.619

Review 3.  Nonhuman Primates and Translational Research-Cardiovascular Disease.

Authors:  Laura A Cox; Michael Olivier; Kimberly Spradling-Reeves; Genesio M Karere; Anthony G Comuzzie; John L VandeBerg
Journal:  ILAR J       Date:  2017-12-01

Review 4.  Animal models of obesity and diabetes mellitus.

Authors:  Maximilian Kleinert; Christoffer Clemmensen; Susanna M Hofmann; Mary C Moore; Simone Renner; Stephen C Woods; Peter Huypens; Johannes Beckers; Martin Hrabe de Angelis; Annette Schürmann; Mostafa Bakhti; Martin Klingenspor; Mark Heiman; Alan D Cherrington; Michael Ristow; Heiko Lickert; Eckhard Wolf; Peter J Havel; Timo D Müller; Matthias H Tschöp
Journal:  Nat Rev Endocrinol       Date:  2018-01-19       Impact factor: 43.330

Review 5.  Marmoset Metabolism, Nutrition, and Obesity.

Authors:  Corinna N Ross; Ricki Colman; Michael Power; Suzette Tardif
Journal:  ILAR J       Date:  2020-12-31

6.  Metabolic Dysregulation in Hepacivirus Infection of Common Marmosets (Callithrix jacchus).

Authors:  Cordelia Manickam; Lynn Wachtman; Amanda J Martinot; Luis D Giavedoni; R Keith Reeves
Journal:  PLoS One       Date:  2017-01-13       Impact factor: 3.240

Review 7.  Utility of Common Marmoset (Callithrix jacchus) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism.

Authors:  Rajagopal N Aravalli; Clifford J Steer
Journal:  Genes (Basel)       Date:  2020-06-30       Impact factor: 4.096

8.  Thioacetamide-induced hepatic fibrosis in the common marmoset.

Authors:  Takashi Inoue; Yukihito Ishizaka; Emi Sasaki; Jun Lu; Takayuki Mineshige; Mikio Yanase; Erika Sasaki; Masayuki Shimoda
Journal:  Exp Anim       Date:  2018-03-22

9.  Hepatic Differentiation of Marmoset Embryonic Stem Cells and Functional Characterization of ESC-Derived Hepatocyte-Like Cells.

Authors:  Rajagopal N Aravalli; Daniel P Collins; Joel H Hapke; Andrew T Crane; Clifford J Steer
Journal:  Hepat Med       Date:  2020-02-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.